Topic: Chutes and Ladders
Merck beefs up digital work with consumer executive; F-star names ex-Immunocore CEO as leader; and Ziopharm’s R&D head joins Spectrum as CMO.
The startup, founded just last year and a JLABS alumnus, is working on next-gen tech.
DFCI's Haining to become VP, Oncology at Merck; Pfizer poaches Quest exec to spearhead digital; and Perrigo swaps CEO for former tobacco executive.
Pfizer CEO Ian Read hands over reins; Nimbus promotes CFO Keiper to CEO spot; and Synlogic names Brennan as permanent CEO.
Brennan took up the position on an interim basis in May when Jose Carlos Gutiérrez-Ramos resigned.
Curis moves up COO as CEO departs; Merck scraps mandatory retirement age to keep CEO Frazier; and Bayer’s Americas pharma head to be CEO at Selecta.
Curis promoted COO James Dentzer to the head of the company, effective immediately, following the departure of CEO Ali Fattaey.
Boehringer’s Corsico jumps to head dev at GSK; Kite’s Polverino takes CSO role at Zymeworks; and Kymera taps former Alnylam executive as CMO.
Chris Corsico left the CMO spot at Boehringer Ingelheim to fill a new role at GlaxoSmithKline: senior vice president of development.
Virion Biotherapeutics announced Monday that Vanessa King and Isabel Najera have signed on as CEO and chief scientific officer, respectively.